Page 732 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 732
CHaPtEr 51 Systemic Lupus Erythematosus 704.e1
MUL t IPLE-CHOICE QUES t IONS
1. Mortality in systemic lupus erythematosus (SLE) 3. Treatment in SLE
A. Has been stable for the past 4 decades A. Relies on immunosuppression
B. Is greater in Caucasians than in other racial groups B. Is different for different races
C. Is secondary to both the disease and the therapy C. Has minimal toxicity
2. Autoantibodies in SLE
A. Are an epiphenomenon
B. Are generally tissue specific
C. Form TLR-activating immune complexes
